世界のマイクロキャリア市場(~2026年):機器別(SUB、SSB、セルカウンター、ろ過)、消耗品別(培地、試薬)、マイクロキャリア別(カチオン性、コラーゲン)、用途別(ワクチン、細胞、遺伝子治療)、エンドユーザー別(医薬品、バイオ医薬品、CRO、CMO)

◆英語タイトル:Microcarrier Market by Equipment (SUB, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Microcarrier (Cationic, Collagen), Application (Vaccine, Cell & Gene Therapy), End User (Pharma, Biopharma, CROs, CMOs) - Global Forecast to 2026
◆商品コード:BT6423
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2021年3月22日
◆ページ数:278
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

マーケッツアンドマーケッツ社は、世界のマイクロキャリア市場規模が2021年17億ドルから2026年29億ドルまで、年平均10.7%成長すると予測しています。本調査資料では、マイクロキャリアの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別(消耗品、機器)分析、用途別(医薬品製造、細胞・遺伝子治療、組織エンジニアリング・再生医療、その他)分析、用途別(半導体、生命科学、材料科学、その他)分析、エンドユーザー別(医薬品&バイオ医薬品、CRO&CMO、学術・研究機関、細胞バンク)分析、地域別分析、競争状況、企業情報などを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のマイクロキャリア市場規模:製品別(消耗品、機器)
・世界のマイクロキャリア市場規模:用途別(医薬品製造、細胞・遺伝子治療、組織エンジニアリング・再生医療、その他)
・世界のマイクロキャリア市場規模:エンドユーザー別(医薬品&バイオ医薬品、CRO&CMO、学術・研究機関、細胞バンク)
・世界のマイクロキャリア市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The microcarriers market is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period.”
Increasing use of single-use bioreactors for bioprocessing, rising investmnet in R&D for developemnt of vaccines and therapeutic protiens, and increasing government funding for cell and gene therapy.

“By product, the consumables segment accounted for the largest share of the microcarriers market”
The microcarriers market by product is categorized into major consuambles and equipments. Consumables dominated the market in 2020. The large share of this segment can be attributed to rising awareness about advantages of serum-free media over sera/serum-containing media, growing demand for reagents in research applications and new product launches by prominent market players.

“Asia Pacific: The fastest-growing region in the microcarriers market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the geographical expasnion by pharmaceutcial companies in emerging countries, collaborations and partnerships between government organizations and biopharmaceutical manufacturers and growth of biopharmaceutical industry.

“North America: the largest share of the microcarriers market”
North America accounted for the largest share of the microcarriers market. Factors such as the to recent approvals for biologics by regulatory authorities, strategic collaborations among well-established players in bioprocesising industry and exponential growth of pharmaceutical sector, especially in the US, are the major factors driving the market growth.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
By Respondent– Supply Side- 70%, Demand Side- 30%
By Designation— Executives- 25%, CXOs, Directors–30%, Managers – 45%
By Region— North America – 40%, Europe – 25%, APAC – 20%, LATAM- 10%, MEA- 5%

The microcarriers market is dominated by a few globally established players such as Thermo Fisher Scientific (US), Sartorius AG (Germany), Danaher Corporation (US), Corning (US), Eppendorf AG (Germany), BD (US), Merck (Germany), ChemoMetec (Denmark), CESCO Bioengineering (Taiwan), HiMedia Laboratories (India), Esco VacciXcell (Singapore), Lonza Group AG (Switzerland), Getinge AB (Sweden), STEMCELL Technologies Inc. (US), Solida Biotech (Germany), Stobbe Pharma (Sweden), Distek, Inc. (US), Celltainer Biotech (Netherlands), G&G Technologies Inc. (US), Tantti (Taiwan), Percell Biolytica (Sweden), PIERRE GUERIN (France), PBS Biotech, Inc. (US), Meissner Filtration Products, Inc. (US), and ABEC, Inc. (US).

Research Coverage:
The report segments the microcarriers market based on region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa), Consumables (Media (Sera/Serum-based Media, Serum-free Media, Other Media), Reagents, Microcarriers (Collagen-coated Microcarriers, Cationic Microcarriers, Protein-coated Microcarriers, Untreated Microcarriers, Other Microcarriers), Application (Biopharmaceutical Production (Vaccine Production, Therapeutic Protein Production), Cell and Gene Therapy, Tissue Engineering and Regenerative Medicine, Other Applications), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations & Contract Manufacturing Organizations, Academic and Research Institutes, Cell Banks)

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the microcarriers market

Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the microcarriers market and provides them information on key market drivers, challenges, and opportunities.

【レポートの目次】

1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.2.1 INCLUSIONS & EXCLUSIONS 42
1.3 MARKET SCOPE 43
FIGURE 1 MICROCARRIERS MARKET 43
1.3.1 YEARS CONSIDERED FOR THE STUDY 44
1.4 CURRENCY 44
1.5 LIMITATIONS 44
1.6 STAKEHOLDERS 45
1.7 SUMMARY OF CHANGES 45
2 RESEARCH METHODOLOGY 47
2.1 RESEARCH DATA 47
2.1.1 SECONDARY DATA 47
2.1.2 PRIMARY DATA 48
FIGURE 2 PRIMARY SOURCES 48
FIGURE 3 MICROCARRIERS MARKET: BREAKDOWN OF PRIMARIES 49
2.1.2.1 Key industry insights 50
2.2 MARKET SIZE ESTIMATION 51
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 – REVENUE SHARE ANALYSIS, 2019 51
FIGURE 5 AVERAGE MARKET SIZE ESTIMATION, 2020 52
FIGURE 6 MICROCARRIERS MARKET: CAGR PROJECTIONS, 2021–2026 53
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 55
FIGURE 7 DATA TRIANGULATION METHODOLOGY 55
2.4 RESEARCH ASSUMPTIONS 56
2.5 RISK ANALYSIS 56
3 EXECUTIVE SUMMARY 57
FIGURE 8 MICROCARRIERS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 57
FIGURE 9 MICROCARRIERS MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION) 58
FIGURE 10 MICROCARRIERS MARKET, BY END USER 2021 VS. 2026 (USD MILLION) 58
FIGURE 11 GEOGRAPHICAL SNAPSHOT: MICROCARRIERS MARKET 59
4 PREMIUM INSIGHTS 60
4.1 MICROCARRIERS MARKET OVERVIEW 60
FIGURE 12 RISING DEMAND FOR CELL-BASED VACCINES TO SUPPORT MARKET GROWTH 60
4.2 NORTH AMERICA: MICROCARRIERS MARKET SHARE, BY PRODUCT & COUNTRY (2020) 61
FIGURE 13 CONSUMABLES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MICROCARRIERS MARKET IN 2020 61
4.3 MICROCARRIERS MARKET SHARE, BY END USER, 2020 61
FIGURE 14 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020 61
4.4 MICROCARRIERS MARKET, BY APPLICATION, 2021 VS. 2026 62
FIGURE 15 BIOPHARMACEUTICAL PRODUCTION WILL CONTINUE TO DOMINATE THE APPLICATIONS MARKET IN 2026 62
4.5 MICROCARRIERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 63
FIGURE 16 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE MICROCARRIERS MARKET FROM 2021 TO 2026 63
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
FIGURE 17 MICROCARRIERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
TABLE 1 MICROCARRIERS MARKET: IMPACT ANALYSIS 65
5.2.1 DRIVERS 65
5.2.1.1 Rising demand for cell-based vaccines 65
5.2.1.2 Technological advancements 66
5.2.1.3 Government funding and venture capital investments for cell and gene research 67
5.2.1.4 Growing preference for single-use technologies 68
5.2.1.5 Increasing R&D funding 68
FIGURE 18 R&D INVESTMENTS BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2010–2025 (USD BILLION) 68
5.2.2 RESTRAINTS 69
5.2.2.1 High cost of cell biology research 69
5.2.2.2 Limitations in the production of high-density cell cultures 69
5.2.3 OPPORTUNITIES 70
5.2.3.1 Rising demand for 3D culture 70
5.2.3.2 Rising mAb production 70
5.2.3.3 Growing research and manufacturing in emerging economies 70
5.2.4 CHALLENGES 71
5.2.4.1 Unavailability of inexpensive serum-free media 71
5.2.4.2 Microcarrier-cell detachment 71
5.3 IMPACT OF COVID-19 ON THE MICROCARRIERS MARKET 71
5.4 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 2 MICROCARRIERS MARKET: PORTER’S FIVE FORCES ANALYSIS 72
5.4.1 THREAT OF NEW ENTRANTS 72
5.4.2 THREAT OF SUBSTITUTES 73
5.4.3 BARGAINING POWER OF SUPPLIERS 73
5.4.4 BARGAINING POWER OF BUYERS 73
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 73
5.5 VALUE CHAIN ANALYSIS 73
FIGURE 19 VALUE CHAIN ANALYSIS OF MICROCARRIERS MARKET: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE 73
5.6 TECHNOLOGICAL ANALYSIS 75
5.6.1 BIOREACTORS 75
TABLE 3 SINGLE-USE BIOREACTORS VS. STAINLESS STEEL BIOREACTORS 75
5.6.2 MICROCARRIERS 76
5.7 ECOSYSTEM ANALYSIS OF THE MICROCARRIERS MARKET 76
FIGURE 20 ECOSYSTEM ANALYSIS 76
TABLE 4 SUPPLY CHAIN ECOSYSTEM 77
5.8 PATENT ANALYSIS 78
FIGURE 21 PATENTS GRANTED FOR MICROCARRIERS/MICROCARRIER CULTURE METHODS, JANUARY 2010–DECEMBER 2020 78
5.9 PRICING ANALYSIS 78
TABLE 5 AVERAGE SELLING PRICE OF LAB-SCALE SINGLE-USE BIOREACTORS, BY REGION (2019) 78
TABLE 6 AVERAGE SELLING PRICE OF MICROCARRIER BEADS, BY REGION (2019) 78
5.10 REGULATORY LANDSCAPE 79
6 MICROCARRIERS MARKET, BY PRODUCT 80
6.1 INTRODUCTION 81
TABLE 7 MICROCARRIERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 81
6.2 CONSUMABLES 81
TABLE 8 MICROCARRIER CONSUMABLES MARKET, BY REGION,
2019–2026 (USD MILLION) 81
TABLE 9 NORTH AMERICA: MICROCARRIER CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 82
TABLE 10 EUROPE: MICROCARRIER CONSUMABLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 82
TABLE 11 ASIA PACIFIC: MICROCARRIER CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 82
TABLE 12 LATIN AMERICA: MICROCARRIER CONSUMABLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 83
TABLE 13 MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 83
6.2.1 MEDIA 83
TABLE 14 MICROCARRIER MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 84
TABLE 15 NORTH AMERICA: MICROCARRIER MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 84
TABLE 16 EUROPE: MICROCARRIER MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 84
TABLE 17 ASIA PACIFIC: MICROCARRIER MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 85
TABLE 18 LATIN AMERICA: MICROCARRIER MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 85
TABLE 19 MICROCARRIER MEDIA MARKET, BY TYPE, 2016–2023 (USD MILLION) 85
6.2.1.1 Serum-based media 86
6.2.1.1.1 The wide availability of serum-based media for research and biopharmaceutical applications will drive segment growth 86
TABLE 20 SERUM-BASED MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 86
TABLE 21 NORTH AMERICA: SERUM-BASED MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 87
TABLE 22 EUROPE: SERUM-BASED MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 87
TABLE 23 ASIA PACIFIC: SERUM-BASED MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 87
TABLE 24 LATIN AMERICA: SERUM-BASED MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 88
6.2.1.2 Serum-free media 88
6.2.1.2.1 The adoption of serum-free media in vaccine production has risen in recent years 88
TABLE 25 SERUM-FREE MEDIA MARKET, BY REGION, 2019–2026 (USD MILLION) 88
TABLE 26 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 89
TABLE 27 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 89
TABLE 28 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 89
TABLE 29 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 90
6.2.1.3 Other media 90
TABLE 30 OTHER MICROCARRIER MEDIA MARKET, BY REGION,
2019–2026 (USD MILLION) 91
TABLE 31 NORTH AMERICA: OTHER MICROCARRIER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 91
TABLE 32 EUROPE: OTHER MICROCARRIER MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 91
TABLE 33 ASIA PACIFIC: OTHER MICROCARRIER MEDIA MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 92
TABLE 34 LATIN AMERICA: OTHER MICROCARRIER MEDIA MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 92
6.2.2 REAGENTS 92
6.2.2.1 Reagents support proliferation, maintain cell metabolism, and protect tissues/cells from damage 92
TABLE 35 MICROCARRIER REAGENTS MARKET, BY REGION,
2019–2026 (USD MILLION) 93
TABLE 36 NORTH AMERICA: MICROCARRIER REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 94
TABLE 37 EUROPE: MICROCARRIER REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 94
TABLE 38 ASIA PACIFIC: MICROCARRIER REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 94
TABLE 39 LATIN AMERICA: MICROCARRIER REAGENTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 95
6.2.3 MICROCARRIER BEADS 95
TABLE 40 MAJOR BRANDS OF MICROCARRIERS 95
TABLE 41 MICROCARRIER BEADS MARKET, BY REGION, 2019–2026 (USD MILLION) 96
TABLE 42 NORTH AMERICA: MICROCARRIER BEADS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 96
TABLE 43 EUROPE: MICROCARRIER BEADS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
TABLE 44 ASIA PACIFIC: MICROCARRIER BEADS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
TABLE 45 LATIN AMERICA: MICROCARRIER BEADS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 97
TABLE 46 MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION) 98
6.2.3.1 Collagen-coated beads 98
6.2.3.1.1 Wide use of collagen-coated microcarriers in biopharma manufacturing to support market growth 98
TABLE 47 COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY REGION,
2019–2026 (USD MILLION) 99
TABLE 48 NORTH AMERICA: COLLAGEN-COATED MICROCARRIER BEADS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 49 EUROPE: COLLAGEN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 50 ASIA PACIFIC: COLLAGEN-COATED MICROCARRIER BEADS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 100
TABLE 51 LATIN AMERICA: COLLAGEN-COATED MICROCARRIER BEADS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 100
6.2.3.2 Cationic beads 100
6.2.3.2.1 Strong cell attachment properties are boosting the use of cationic beads 100
TABLE 52 CATIONIC MICROCARRIER BEADS MARKET, BY REGION,
2019–2026 (USD MILLION) 101
TABLE 53 NORTH AMERICA: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 101
TABLE 54 EUROPE: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 101
TABLE 55 ASIA PACIFIC: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 102
TABLE 56 LATIN AMERICA: CATIONIC MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 102
6.2.3.3 Protein-coated beads 102
6.2.3.3.1 The shift from animal-based to animal-free products will drive the market for protein-coated beads 102
TABLE 57 PROTEIN-COATED MICROCARRIER BEADS MARKET, BY REGION,
2019–2026 (USD MILLION) 103
TABLE 58 NORTH AMERICA: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 103
TABLE 59 EUROPE: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 103
TABLE 60 ASIA PACIFIC: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
TABLE 61 LATIN AMERICA: PROTEIN-COATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 104
6.2.3.4 Untreated beads 104
6.2.3.4.1 Properties such as low cell attachment efficiency likely to reduce the adoption of untreated beads 104
TABLE 62 UNTREATED MICROCARRIER BEADS MARKET, BY REGION,
2019–2026 (USD MILLION) 105
TABLE 63 NORTH AMERICA: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 105
TABLE 64 EUROPE: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 105
TABLE 65 ASIA PACIFIC: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
TABLE 66 LATIN AMERICA: UNTREATED MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 106
6.2.3.5 Other microcarrier beads 106
TABLE 67 OTHER MICROCARRIER BEADS MARKET, BY REGION,
2019–2026 (USD MILLION) 107
TABLE 68 NORTH AMERICA: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 107
TABLE 69 EUROPE: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 107
TABLE 70 ASIA PACIFIC: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 108
TABLE 71 LATIN AMERICA: OTHER MICROCARRIER BEADS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 108
6.3 EQUIPMENT 108
TABLE 72 MICROCARRIER EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 109
TABLE 73 NORTH AMERICA: MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 109
TABLE 74 EUROPE: MICROCARRIER EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 109
TABLE 75 ASIA PACIFIC: MICROCARRIER EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
TABLE 76 LATIN AMERICA: MICROCARRIER EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 110
TABLE 77 MICROCARRIER EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION) 110
6.3.1 BIOREACTORS 111
TABLE 78 MICROCARRIER BIOREACTORS MARKET, BY REGION,
2019–2026 (USD MILLION) 111
TABLE 79 NORTH AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 111
TABLE 80 EUROPE: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 112
TABLE 81 ASIA PACIFIC: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 112
TABLE 82 LATIN AMERICA: MICROCARRIER BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 112
TABLE 83 MICROCARRIERS BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 113
6.3.1.1 Stainless steel bioreactors 113
6.3.1.1.1 Stainless steel bioreactors are used in large-scale production and dominate the market 113
TABLE 84 STAINLESS STEEL BIOREACTORS MARKET, BY REGION,
2019–2026 (USD MILLION) 113
TABLE 85 NORTH AMERICA: STAINLESS STEEL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 86 EUROPE: STAINLESS STEEL BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 114
TABLE 87 ASIA PACIFIC: STAINLESS STEEL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 88 LATIN AMERICA: STAINLESS STEEL BIOREACTORS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 115
6.3.1.2 Single-use bioreactors 115
6.3.1.2.1 Product launches and shift from stainless steel to single-use bioreactors for biopharmaceutical applications likely to boost the segment growth 115
TABLE 89 SINGLE-USE BIOREACTORS MARKET, BY REGION,
2019–2026 (USD MILLION) 116
TABLE 90 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 116
TABLE 91 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 116
TABLE 92 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 117
TABLE 93 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 117
6.3.2 CULTURE VESSELS 117
6.3.2.1 Advances in 3D cell culture vessels and recent product launches drive the culture vessels market 117
TABLE 94 MICROCARRIER CULTURE VESSELS MARKET, BY REGION,
2019–2026 (USD MILLION) 118
TABLE 95 NORTH AMERICA: MICROCARRIER CULTURE VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 118
TABLE 96 EUROPE: MICROCARRIER CULTURE VESSELS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 119
TABLE 97 ASIA PACIFIC: MICROCARRIER CULTURE VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 119
TABLE 98 LATIN AMERICA: MICROCARRIER CULTURE VESSELS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 119
6.3.3 FILTRATION & SEPARATION EQUIPMENT 120
6.3.3.1 Adoption of advanced filtration and separation systems has risen in bioprocess applications 120
TABLE 99 MICROCARRIER FILTRATION & SEPARATION EQUIPMENT MARKET,
BY REGION, 2019–2026 (USD MILLION) 121
TABLE 100 NORTH AMERICA: MICROCARRIER FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 101 EUROPE: MICROCARRIER FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 121
TABLE 102 ASIA PACIFIC: MICROCARRIER FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
TABLE 103 LATIN AMERICA: MICROCARRIER FILTRATION & SEPARATION EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 122
6.3.4 CELL COUNTERS 122
6.3.4.1 Rising preference for automated cell counters accelerates the growth of the segment 122
TABLE 104 CELL COUNTERS MARKET, BY REGION, 2019–2026 (USD MILLION) 123
TABLE 105 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 123
TABLE 106 EUROPE: CELL COUNTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
TABLE 107 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
TABLE 108 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 124
6.3.5 OTHER EQUIPMENT 125
TABLE 109 OTHER MICROCARRIER EQUIPMENT MARKET, BY REGION,
2019–2026 (USD MILLION) 125
TABLE 110 NORTH AMERICA: OTHER MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 126
TABLE 111 EUROPE: OTHER MICROCARRIER EQUIPMENT MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 126
TABLE 112 ASIA PACIFIC: OTHER MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 126
TABLE 113 LATIN AMERICA: OTHER MICROCARRIER EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 127
7 MICROCARRIERS MARKET, BY APPLICATION 128
7.1 INTRODUCTION 129
TABLE 114 MICROCARRIERS MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 129
7.2 BIOPHARMACEUTICAL PRODUCTION 130
TABLE 115 MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2019–2026 (USD MILLION) 130
TABLE 116 NORTH AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 130
TABLE 117 EUROPE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 131
TABLE 118 ASIA PACIFIC: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 131
TABLE 119 LATIN AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 131
TABLE 120 MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 132
7.2.1 VACCINE PRODUCTION 132
7.2.1.1 Rising vaccine development to fuel the growth of this segment 132
TABLE 121 MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY REGION,
2019–2026 (USD MILLION) 133
TABLE 122 NORTH AMERICA: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 133
TABLE 123 EUROPE: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 133
TABLE 124 ASIA PACIFIC: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 134
TABLE 125 LATIN AMERICA: MICROCARRIERS MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 134
7.2.2 THERAPEUTIC PROTEIN PRODUCTION 134
7.2.2.1 With the increased productivity and decreased cell turnover and lysis rate, the adoption of microcarriers in therapeutic proteins production is increasing 134
TABLE 126 MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2019–2026 (USD MILLION) 135
TABLE 127 NORTH AMERICA: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 135
TABLE 128 EUROPE: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 136
TABLE 129 ASIA PACIFIC: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 136
TABLE 130 LATIN AMERICA: MICROCARRIERS MARKET FOR THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2019–2026 (USD MILLION) 136
7.3 CELL & GENE THERAPY 137
7.3.1 TECHNOLOGICAL ADVANCEMENTS AND ADOPTION OF SINGLE-USE TECHNOLOGIES DRIVE SEGMENT GROWTH 137
TABLE 131 MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY REGION,
2019–2026 (USD MILLION) 137
TABLE 132 NORTH AMERICA: MICROCARRIERS MARKET & CELL AND GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION) 138
TABLE 133 EUROPE: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION) 138
TABLE 134 ASIA PACIFIC: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION) 138
TABLE 135 LATIN AMERICA: MICROCARRIERS MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION) 139
7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE 139
7.4.1 AVAILABILITY OF FUNDING AND GROWING RESEARCH ACTIVITY IN REGENERATIVE MEDICINE ACCELERATE MARKET GROWTH 139
TABLE 136 MICROCARRIERS MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2019–2026 (USD MILLION) 139
TABLE 137 NORTH AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 140
TABLE 138 EUROPE: MICROCARRIERS MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 140
TABLE 139 ASIA PACIFIC: MICROCARRIERS MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 140
TABLE 140 LATIN AMERICA: MICROCARRIERS MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2019–2026 (USD MILLION) 141
7.5 OTHER APPLICATIONS 141
TABLE 141 MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY REGION,
2019–2026 (USD MILLION) 141
TABLE 142 NORTH AMERICA: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 143 EUROPE: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 144 ASIA PACIFIC: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 142
TABLE 145 LATIN AMERICA: MICROCARRIERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 143
8 MICROCARRIERS MARKET, BY END USER 144
8.1 INTRODUCTION 145
TABLE 146 MICROCARRIERS MARKET, BY END USER, 2019–2026 (USD MILLION) 145
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 145
8.2.1 PHARMA & BIOTECH COMPANIES HOLD THE LARGEST SHARE OF THE END-USER MARKET 145
TABLE 147 MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION) 146
TABLE 148 NORTH AMERICA: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 146
TABLE 149 EUROPE: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 147
TABLE 150 ASIA PACIFIC: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 147
TABLE 151 LATIN AMERICA: MICROCARRIERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION) 147
8.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS 148
8.3.1 RISING INVESTMENTS AND FACILITY EXPANSION IN BIOPROCESSING SUPPORT SEGMENT GROWTH 148
TABLE 152 MICROCARRIERS MARKET FOR CROS & CMOS, BY REGION,
2019–2026 (USD MILLION) 149
TABLE 153 NORTH AMERICA: MICROCARRIERS MARKET FOR CROS & CMOS, BY COUNTRY, 2019–2026 (USD MILLION) 149
TABLE 154 EUROPE: MICROCARRIERS MARKET FOR CROS & CMOS, BY COUNTRY, 2019–2026 (USD MILLION) 149
TABLE 155 ASIA PACIFIC: MICROCARRIERS MARKET FOR CROS & CMOS, BY COUNTRY, 2019–2026 (USD MILLION) 150
TABLE 156 LATIN AMERICA: MICROCARRIERS MARKET FOR CROS & CMOS, BY COUNTRY, 2019–2026 (USD MILLION) 150
8.4 ACADEMIC & RESEARCH INSTITUTES 150
8.4.1 STRONG FOCUS ON DEVELOPMENT OF NEXT-GENERATION GENE THERAPIES FOR RARE DISORDERS TO FUEL SEGMENT GROWTH 150
TABLE 157 MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION) 151
TABLE 158 NORTH AMERICA: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 151
TABLE 159 EUROPE: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 152
TABLE 160 ASIA PACIFIC: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 152
TABLE 161 LATIN AMERICA: MICROCARRIERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION) 152
8.5 CELL BANKS 153
8.5.1 INCREASE IN DEMAND FOR STEM CELLS IN STEM CELL STUDIES TO FUEL SEGMENT GROWTH 153
TABLE 162 MICROCARRIERS MARKET FOR CELL BANKS, BY REGION,
2019–2026 (USD MILLION) 153
TABLE 163 NORTH AMERICA: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2019–2026 (USD MILLION) 153
TABLE 164 EUROPE: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY,
2019–2026 (USD MILLION) 154
TABLE 165 ASIA PACIFIC: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2019–2026 (USD MILLION) 154
TABLE 166 LATIN AMERICA: MICROCARRIERS MARKET FOR CELL BANKS, BY COUNTRY, 2019–2026 (USD MILLION) 154

9 MICROCARRIERS MARKET, BY REGION 155
9.1 INTRODUCTION 156
TABLE 167 MICROCARRIERS MARKET, BY REGION, 2019–2026 (USD MILLION) 156
9.2 NORTH AMERICA 156
FIGURE 22 NORTH AMERICA: MICROCARRIERS MARKET SNAPSHOT 157
TABLE 168 NORTH AMERICA: MICROCARRIERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 157
TABLE 169 NORTH AMERICA: MICROCARRIER CONSUMABLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 158
TABLE 170 NORTH AMERICA: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 171 NORTH AMERICA: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 158
TABLE 172 NORTH AMERICA: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 173 NORTH AMERICA: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 159
TABLE 174 NORTH AMERICA: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 159
TABLE 175 NORTH AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 160
TABLE 176 NORTH AMERICA: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 160
TABLE 177 NORTH AMERICA: MICROCARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 160
9.2.1 US 161
9.2.1.1 The US is a leading global market for microcarrier products 161
TABLE 178 US: MICROCARRIERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 161
TABLE 179 US: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 162
TABLE 180 US: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 181 US: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 182 US: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 183 US: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 163
TABLE 184 US: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 163
TABLE 185 US: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 164
TABLE 186 US: MICROCARRIERS MARKET, BY END USER, 2019–2026 (USD MILLION) 164
9.2.2 CANADA 164
9.2.2.1 Rising government investment in stem cell research boosts the Canadian microcarriers market 164
TABLE 187 CANADA: MICROCARRIERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 165
TABLE 188 CANADA: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 189 CANADA: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 165
TABLE 190 CANADA: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 191 CANADA: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 192 CANADA: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 166
TABLE 193 CANADA: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 167
TABLE 194 CANADA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 167
TABLE 195 CANADA: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 167
9.3 EUROPE 168
TABLE 196 KEY PUBLIC EUROPEAN ADVANCED THERAPY COMPANIES 168
TABLE 197 EUROPE: MICROCARRIERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 169
TABLE 198 EUROPE: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 199 EUROPE: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 169
TABLE 200 EUROPE: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 201 EUROPE: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 202 EUROPE: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 170
TABLE 203 EUROPE: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 171
TABLE 204 EUROPE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 171
TABLE 205 EUROPE: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 171
TABLE 206 EUROPE: MICROCARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 172
9.3.1 GERMANY 172
9.3.1.1 Germany holds the largest share of the European microcarriers market 172
TABLE 207 GERMANY: MICROCARRIERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 173
TABLE 208 GERMANY: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 209 GERMANY: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 210 GERMANY: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 211 GERMANY: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 212 GERMANY: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 213 GERMANY: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 175
TABLE 214 GERMANY: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 215 GERMANY: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 175
9.3.2 FRANCE 176
9.3.2.1 Increase in funding to boost R&D activities is projected to drive the growth of the French microcarriers market 176
TABLE 216 FRANCE: MICROCARRIERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 176
TABLE 217 FRANCE: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 176
TABLE 218 FRANCE: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 219 FRANCE: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 220 FRANCE: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 177
TABLE 221 FRANCE: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 178
TABLE 222 FRANCE: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 178
TABLE 223 FRANCE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 224 FRANCE: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 179
9.3.3 UK 179
9.3.3.1 Focus on cancer research funding will increase the demand for microcarriers in the UK 179
TABLE 225 UK: MICROCARRIERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 180
TABLE 226 UK: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 227 UK: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 228 UK: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 229 UK: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 230 UK: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 181
TABLE 231 UK: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 182
TABLE 232 UK: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 182
TABLE 233 UK: MICROCARRIERS MARKET, BY END USER, 2019–2026 (USD MILLION) 182
9.3.4 ITALY 183
9.3.4.1 Government support for life science research to fuel the adoption of microcarrier-based cell culture products in Italy 183
TABLE 234 ITALY: MICROCARRIERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 183
TABLE 235 ITALY: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 183
TABLE 236 ITALY: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 237 ITALY: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 238 ITALY: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 184
TABLE 239 ITALY: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 240 ITALY: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 185
TABLE 241 ITALY: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 242 ITALY: MICROCARRIERS MARKET, BY END USER, 2019–2026 (USD MILLION) 186
9.3.5 SPAIN 186
9.3.5.1 Facility expansion and investment in bioprocessing technologies to aid market growth in Spain 186
TABLE 243 SPAIN: MICROCARRIERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 186
TABLE 244 SPAIN: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 245 SPAIN: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 246 SPAIN: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 247 SPAIN: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 248 SPAIN: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 188
TABLE 249 SPAIN: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 188
TABLE 250 SPAIN: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 251 SPAIN: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 189
9.3.6 REST OF EUROPE 189
TABLE 252 ROE: MICROCARRIERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 190
TABLE 253 ROE: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 254 ROE: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 255 ROE: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION) 191
TABLE 256 ROE: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 257 ROE: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 191
TABLE 258 ROE: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 192
TABLE 259 ROE: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 192
TABLE 260 ROE: MICROCARRIERS MARKET, BY END USER, 2019–2026 (USD MILLION) 192
9.4 ASIA PACIFIC 193
FIGURE 23 ASIA PACIFIC: MICROCARRIERS MARKET SNAPSHOT 193
TABLE 261 APAC: MICROCARRIERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 194
TABLE 262 APAC: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 263 APAC: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 264 APAC: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 265 APAC: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 266 APAC: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 267 APAC: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 196
TABLE 268 APAC: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 196
TABLE 269 APAC: MICROCARRIERS MARKET, BY END USER, 2019–2026 (USD MILLION) 196
TABLE 270 APAC: MICROCARRIERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 197
9.4.1 CHINA 197
9.4.1.1 China to register the highest growth in the Asia Pacific microcarriers market during the forecast period 197
TABLE 271 CHINA: MICROCARRIERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 198
TABLE 272 CHINA: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 273 CHINA: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 198
TABLE 274 CHINA: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 275 CHINA: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 276 CHINA: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 277 CHINA: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 200
TABLE 278 CHINA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 279 CHINA: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 200
9.4.2 JAPAN 201
9.4.2.1 Strategic developments by pharmaceutical companies to drive the market for microcarrier cell culture in Japan 201
TABLE 280 JAPAN: MICROCARRIERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 201
TABLE 281 JAPAN: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 282 JAPAN: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 283 JAPAN: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 202
TABLE 284 JAPAN: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 285 JAPAN: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 203
TABLE 286 JAPAN: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 203
TABLE 287 JAPAN: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 288 JAPAN: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 204
9.4.3 INDIA 204
9.4.3.1 Expansion of manufacturing facilities is likely to support the growth of the market in India 204
TABLE 289 INDIA: MICROCARRIERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 205
TABLE 290 INDIA: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 291 INDIA: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 205
TABLE 292 INDIA: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 293 INDIA: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 294 INDIA: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 206
TABLE 295 INDIA: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 207
TABLE 296 INDIA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 297 INDIA: MICROCARRIERS MARKET, BY END USER, 2019–2026 (USD MILLION) 207
9.4.4 REST OF ASIA PACIFIC 208
TABLE 298 ROAPAC: MICROCARRIERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 208
TABLE 299 ROAPAC: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 208
TABLE 300 ROAPAC: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 301 ROAPAC: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 302 ROAPAC: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 303 ROAPAC: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 210
TABLE 304 ROAPAC: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 210
TABLE 305 ROAPAC: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 306 ROAPAC: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 211
9.5 LATIN AMERICA 211
TABLE 307 LATIN AMERICA: MICROCARRIERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 211
TABLE 308 LATIN AMERICA: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 211
TABLE 309 LATIN AMERICA: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABLE 310 LATIN AMERICA: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABLE 311 LATIN AMERICA: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABLE 312 LATIN AMERICA: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 213
TABLE 313 LATIN AMERICA: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 213
TABLE 314 LATIN AMERICA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 315 LATIN AMERICA: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 214
TABLE 316 LATIN AMERICA: MICROCARRIERS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 214
9.5.1 BRAZIL 214
9.5.1.1 Brazil dominates the LATAM microcarriers market 214
TABLE 317 BRAZIL: MICROCARRIERS MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 215
TABLE 318 BRAZIL: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 215
TABLE 319 BRAZIL: MICROCARRIER MEDIA MARKET, BY TYPE,
2019–2026 (USD MILLION) 215
TABLE 320 BRAZIL: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 216
TABLE 321 BRAZIL: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 216
TABLE 322 BRAZIL: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 216
TABLE 323 BRAZIL: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 217
TABLE 324 BRAZIL: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 217
TABLE 325 BRAZIL: MICROCARRIERS MARKET, BY END USER,
2019–2026 (USD MILLION) 217
9.5.2 REST OF LATIN AMERICA 218
TABLE 326 ROLA: MICROCARRIERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 218
TABLE 327 ROLA: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 218
TABLE 328 ROLA: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 219
TABLE 329 ROLA: MICROCARRIER BEADS MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 330 ROLA: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 331 ROLA: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 220
TABLE 332 ROLA: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 220
TABLE 333 ROLA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 334 ROLA: MICROCARRIERS MARKET, BY END USER, 2019–2026 (USD MILLION) 221
9.6 MIDDLE EAST & AFRICA 221
9.6.1 DEVELOPMENT AND COMMERCIALIZATION OF CELL AND GENE THERAPY IN MEA SUPPORTS THE MARKET GROWTH 221
TABLE 335 MEA: MICROCARRIERS MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 221
TABLE 336 MEA: MICROCARRIER CONSUMABLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 337 MEA: MICROCARRIER MEDIA MARKET, BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 338 MEA: MICROCARRIER BEADS MARKET, BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 339 MEA: MICROCARRIER EQUIPMENT MARKET, BY TYPE,
2019–2026 (USD MILLION) 223
TABLE 340 MEA: MICROCARRIER BIOREACTORS MARKET, BY TYPE,
2019–2026 (USD MILLION) 223
TABLE 341 MEA: MICROCARRIERS MARKET, BY APPLICATION,
2019–2026 (USD MILLION) 223
TABLE 342 MEA: MICROCARRIERS MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2019–2026 (USD MILLION) 224
TABLE 343 MEA: MICROCARRIERS MARKET, BY END USER, 2019–2026 (USD MILLION) 224
10 COMPETITIVE LANDSCAPE 225
10.1 OVERVIEW 225
10.2 MARKET EVALUATION FRAMEWORK 225
TABLE 344 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES, THE MAJOR STRATEGY ADOPTED BY PLAYERS 225
10.3 MARKET SHARE ANALYSIS 226
FIGURE 24 MICROCARRIERS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020 226
10.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 227
10.5 COMPANY EVALUATION QUADRANT 227
10.5.1 STARS 228
10.5.2 EMERGING LEADERS 228
10.5.3 PERVASIVE 228
10.5.4 EMERGING COMPANIES 228
FIGURE 26 MICROCARRIERS MARKET: COMPANY EVALUATION QUADRANT, 2020 229
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 230
10.6.1 PROGRESSIVE COMPANIES 230
10.6.2 STARTING BLOCKS 230
10.6.3 RESPONSIVE COMPANIES 230
10.6.4 DYNAMIC COMPANIES 230
FIGURE 27 MICROCARRIERS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020 231
10.7 COMPANY PRODUCT FOOTPRINT 232
TABLE 345 PRODUCT PORTFOLIO ANALYSIS: MICROCARRIERS MARKET (2020) 232
10.8 COMPANY GEOGRAPHIC FOOTPRINT 233
TABLE 346 GEOGRAPHIC REVENUE MIX: MICROCARRIERS MARKET (2020) 233
10.9 COMPETITIVE SCENARIO 234
TABLE 347 MICROCARRIERS MARKET: PRODUCT LAUNCHES, JANUARY 2018–JANUARY 2021 234
TABLE 348 MICROCARRIERS MARKET: DEALS, JANUARY 2019–JANUARY 2021 234
TABLE 349 MICROCARRIERS MARKET: OTHER DEVELOPMENTS, JANUARY 2018–JANUARY 2021 235
11 COMPANY PROFILES 236
11.1 KEY MARKET PLAYERS 236
(Business overview, Products offered, Recent developments, SWOT analysis, and MNM View)*
11.1.1 THERMO FISHER SCIENTIFIC 236
FIGURE 28 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 237
11.1.2 CORNING 241
FIGURE 29 CORNING: COMPANY SNAPSHOT 241
11.1.3 MERCK 245
FIGURE 30 MERCK KGAA: COMPANY SNAPSHOT 245
11.1.4 SARTORIUS 250
FIGURE 31 SARTORIUS AG: COMPANY SNAPSHOT 250
11.1.5 DANAHER CORPORATION 255
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT 255
11.1.6 BECTON, DICKINSON AND COMPANY 260
FIGURE 33 BD: COMPANY SNAPSHOT 260
11.1.7 EPPENDORF AG 262
FIGURE 34 EPPENDORF: COMPANY SNAPSHOT 262
11.1.8 LONZA GROUP 264
FIGURE 35 LONZA GROUP AG: COMPANY SNAPSHOT 264
11.1.9 GETINGE AB 267
FIGURE 36 GETINGE AB: COMPANY SNAPSHOT 267
11.1.10 CHEMOMETEC 269
FIGURE 37 CHEMOMETEC A/S: COMPANY SNAPSHOT 269
11.1.11 CESCO BIOENGINEERING 271
11.1.12 HIMEDIA LABORATORIES 273
11.1.13 ESCO VACCIXCELL 275
11.2 OTHER PLAYERS 276
11.2.1 STEMCELL TECHNOLOGIES 276
11.2.2 SOLIDA BIOTECH 278
11.2.3 STOBBE PHARMA 279
11.2.4 DISTEK 281
11.2.5 CELLTAINER BIOTECH 282
11.2.6 G&G TECHNOLOGIES 283
11.2.7 TANTTI 284
*Details on Business overview, Products offered, Recent developments, SWOT analysis, and MNM View might not be captured in case of unlisted companies.
12 APPENDIX 285
12.1 DISCUSSION GUIDE 285
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 288
12.3 AVAILABLE CUSTOMIZATIONS 290
12.4 RELATED REPORTS 290
12.5 AUTHOR DETAILS 291

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のマイクロキャリア市場(~2026年):機器別(SUB、SSB、セルカウンター、ろ過)、消耗品別(培地、試薬)、マイクロキャリア別(カチオン性、コラーゲン)、用途別(ワクチン、細胞、遺伝子治療)、エンドユーザー別(医薬品、バイオ医薬品、CRO、CMO)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆